TGM2 and nonpapillary renal cell carcinoma: In this review, TGase 2 is analyzed as a precise therapeutic target for ccRCC, considering how TGase 2 expression is increased, why the increase of TGase 2 is specifically related to ccRCC, and what the role of TGase 2 is that makes it critical to ccRCC survival.